-
1
-
-
0034925369
-
Clinical evaluation of a patient presenting with headache
-
Purdy RA. Clinical evaluation of a patient presenting with headache. Med Clin North Am 2001; 85: 847-63.
-
(2001)
Med Clin North Am
, vol.85
, pp. 847-863
-
-
Purdy, R.A.1
-
2
-
-
0034913120
-
Evaluation and management of headache in the emergency room
-
Ward TN, Levin M, Phillips JM. Evaluation and management of headache in the emergency room. Med Clin North Am 2001; 85: 971-86.
-
(2001)
Med Clin North Am
, vol.85
, pp. 971-986
-
-
Ward, T.N.1
Levin, M.2
Phillips, J.M.3
-
3
-
-
0006913737
-
Burden of migraine in the United States: Disability and economic costs
-
Hu HX, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999; 159: 813-8.
-
(1999)
Arch Intern Med
, vol.159
, pp. 813-818
-
-
Hu, H.X.1
Markson, L.E.2
Lipton, R.B.3
Stewart, W.F.4
Berger, M.L.5
-
4
-
-
0026728886
-
Undiagnosed migraine headaches: A comparison of symptom-based and reported physician diagnosis
-
Lipton RB, Stewart WF, Celenrano DD, Reed ML. Undiagnosed migraine headaches: a comparison of symptom-based and reported physician diagnosis. Arch Intern Med 1992; 152: 1273-8.
-
(1992)
Arch Intern Med
, vol.152
, pp. 1273-1278
-
-
Lipton, R.B.1
Stewart, W.F.2
Celenrano, D.D.3
Reed, M.L.4
-
5
-
-
0034883732
-
Prevalence and burden of migraine in the United States: Data from the American migraine study II
-
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache 2001; 41: 64-7.
-
(2001)
Headache
, vol.41
, pp. 64-67
-
-
Lipton, R.B.1
Stewart, W.F.2
Diamond, S.3
Diamond, M.L.4
Reed, M.5
-
6
-
-
0034826748
-
Migraña: Implicaciones laborales, discapacidad y solicitud de servicios de salud en Colombia
-
Aicardi E, Reynales H, Valencia D. Migraña: Implicaciones laborales, discapacidad y solicitud de servicios de salud en Colombia. Rev Neurol 2001; 32: 1001-5.
-
(2001)
Rev Neurol
, vol.32
, pp. 1001-1005
-
-
Aicardi, E.1
Reynales, H.2
Valencia, D.3
-
7
-
-
0012758194
-
Estudio neuroepidemiológico de cefaleas en Piedecuesta, Santander
-
Pradilla G, Vesga BE, Díaz LA, Pinto NX, Baldovino BP. Estudio neuroepidemiológico de cefaleas en Piedecuesta, Santander. Acta Neurológica Colombiana 2001; 17: 246-7.
-
(2001)
Acta Neurológica Colombiana
, vol.17
, pp. 246-247
-
-
Pradilla, G.1
Vesga, B.E.2
Díaz, L.A.3
Pinto, N.X.4
Baldovino, B.P.5
-
8
-
-
0036627191
-
Neuroepidemiología en el Oriente colombiano
-
Grupo GENECO
-
Pradilla G, Vesga BE, León-Sarmiento FE, Bautista LE, Núñez LC, Vesga E, et al. Grupo GENECO. Neuroepidemiología en el Oriente colombiano. Rev Neurol 2002; 34: 1035-43.
-
(2002)
Rev Neurol
, vol.34
, pp. 1035-1043
-
-
Pradilla, G.1
Vesga, B.E.2
León-Sarmiento, F.E.3
Bautista, L.E.4
Núñez, L.C.5
Vesga, E.6
-
9
-
-
0034887548
-
Migraine diagnosis and treatment: Results from the American Migraine Study II
-
Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001; 41: 638-45.
-
(2001)
Headache
, vol.41
, pp. 638-645
-
-
Lipton, R.B.1
Diamond, S.2
Reed, M.3
Diamond, M.L.4
Stewart, W.F.5
-
10
-
-
0037076302
-
Diagnostic lessons from the spectrum study
-
Lipton RB, Cady RK, Stewart WF, Wilks K, Hall C. Diagnostic lessons from the spectrum study. Neurology 2002; 58 (Suppl 6): S27-31.
-
(2002)
Neurology
, vol.58
, Issue.SUPPL. 6
-
-
Lipton, R.B.1
Cady, R.K.2
Stewart, W.F.3
Wilks, K.4
Hall, C.5
-
11
-
-
0034626361
-
The diagnostic value of historical features in primary headache syndromes
-
Smetana GW. The diagnostic value of historical features in primary headache syndromes. Arch Intem Med 2000; 160: 2729-37.
-
(2000)
Arch Intem Med
, vol.160
, pp. 2729-2737
-
-
Smetana, G.W.1
-
12
-
-
0034945368
-
Diagnosis of migraine, empirical analysis of a large clinical simple of atypical migraine (IHS 1.7) patients and proposed revision of the IHS criteria
-
Rains JC, Penzien DB, Lipchick GL, Ramadan NM. Diagnosis of migraine, empirical analysis of a large clinical simple of atypical migraine (IHS 1.7) patients and proposed revision of the IHS criteria. Cephalalgia 2001; 21: 583-95.
-
(2001)
Cephalalgia
, vol.21
, pp. 583-595
-
-
Rains, J.C.1
Penzien, D.B.2
Lipchick, G.L.3
Ramadan, N.M.4
-
13
-
-
0037076421
-
The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine
-
Diamond ML. The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine. Neurology 2002; 58 (Suppl 6): S3-9.
-
(2002)
Neurology
, vol.58
, Issue.SUPPL. 6
-
-
Diamond, M.L.1
-
14
-
-
0037076362
-
Sinus headache or migraine? Considerations in making a differential diagnosis
-
Cady RK, Schreiber CP. Sinus headache or migraine? Considerations in making a differential diagnosis. Neurology 2002; 58 (Suppl 6): S10-4.
-
(2002)
Neurology
, vol.58
, Issue.SUPPL. 6
-
-
Cady, R.K.1
Schreiber, C.P.2
-
15
-
-
0037076422
-
Migraine and tension-type headache: An assessment of challenges in diagnosis
-
Kaniecki RG. Migraine and tension-type headache: an assessment of challenges in diagnosis. Neurology 2002; 58 (Suppl 6): S15-20.
-
(2002)
Neurology
, vol.58
, Issue.SUPPL. 6
-
-
Kaniecki, R.G.1
-
16
-
-
0037345762
-
Migraine preventive medication reduces resource utilization
-
Silberstein SD, Winner PK, Chmiel JJ. Migraine preventive medication reduces resource utilization. Headache 2003; 43: 171-8.
-
(2003)
Headache
, vol.43
, pp. 171-178
-
-
Silberstein, S.D.1
Winner, P.K.2
Chmiel, J.J.3
-
17
-
-
0036616193
-
The economic impact of migraine: An analysis of direct and indirect costs
-
Edmeads J, Mackell JA. The economic impact of migraine: an analysis of direct and indirect costs. Headache 2002; 42: 501-9.
-
(2002)
Headache
, vol.42
, pp. 501-509
-
-
Edmeads, J.1
Mackell, J.A.2
-
19
-
-
1442265540
-
The International Classification of Headache Disorders
-
Headache Subcommittee of the International Headache Society
-
The International Classification of Headache Disorders. Headache Subcommittee of the International Headache Society. Cephalalgia 2004; 24 (Suppl 1): 1-150.
-
(2004)
Cephalalgia
, vol.24
, Issue.SUPPL. 1
, pp. 1-150
-
-
-
20
-
-
0344267641
-
Epidemiology of chronic daily headache in the general population
-
Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999; 39: 190-6.
-
(1999)
Headache
, vol.39
, pp. 190-196
-
-
Castillo, J.1
Muñoz, P.2
Guitera, V.3
Pascual, J.4
-
22
-
-
0001694653
-
Migraine: Diagnosis and treatment
-
Silberstein SD, Lipton RB, Dalessio DJ, eds. New York: Oxford University Press
-
Silberstein SL, Saper JR, Freitag FG. Migraine: diagnosis and treatment. In Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's headache and other head pain. 7 ed. New York: Oxford University Press; 2001. p. 121-237.
-
(2001)
Wolff's Headache and Other Head Pain. 7 Ed.
, pp. 121-237
-
-
Silberstein, S.L.1
Saper, J.R.2
Freitag, F.G.3
-
24
-
-
0043245854
-
Pharmacological approaches to migraine
-
Diener HCH. Pharmacological approaches to migraine. J Neural Transin 2003 (Suppl); 64: 35-63.
-
(2003)
J Neural Transin
, vol.64
, Issue.SUPPL.
, pp. 35-63
-
-
Diener, H.C.H.1
-
25
-
-
1442359548
-
Topiramate for migraine prevention: A randomized controlled trial
-
Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al, MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004; 291: 965-73.
-
(2004)
JAMA
, vol.291
, pp. 965-973
-
-
Brandes, J.L.1
Saper, J.R.2
Diamond, M.3
Couch, J.R.4
Lewis, D.W.5
Schmitt, J.6
-
26
-
-
2342461018
-
Topiramate in migraine prevention: Results of a large controlled trial
-
Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004; 61: 490-5.
-
(2004)
Arch Neurol
, vol.61
, pp. 490-495
-
-
Silberstein, S.D.1
Neto, W.2
Schmitt, J.3
Jacobs, D.4
-
28
-
-
0037540062
-
Preventive treatment for migraine and tension-type headaches. Do drugs heaving effects on muscle spasm and tone have a role?
-
Freitag FG. Preventive treatment for migraine and tension-type headaches. Do drugs heaving effects on muscle spasm and tone have a role? CNS Drugs 2003; 17: 373-81.
-
(2003)
CNS Drugs
, vol.17
, pp. 373-381
-
-
Freitag, F.G.1
-
29
-
-
0346074482
-
Long-term use of botulinum toxin type A (Botox) in the treatment of episodic and chronic migraine headaches
-
Mauskop A. Long-term use of botulinum toxin type A (Botox) in the treatment of episodic and chronic migraine headaches. Neurology 2002; 58 (Suppl 3): A497.
-
(2002)
Neurology
, vol.58
, Issue.SUPPL. 3
-
-
Mauskop, A.1
-
30
-
-
0037874443
-
Botulinum toxin type A (Botox) therapy for intractable headache
-
Troost BT. Botulinum toxin type A (Botox) therapy for intractable headache. Headache 2002; 42: 435.
-
(2002)
Headache
, vol.42
, pp. 435
-
-
Troost, B.T.1
-
31
-
-
0036840845
-
Use of botulinum toxins for chronic headaches: A focused review
-
Loder E, Biondi D. Use of botulinum toxins for chronic headaches: a focused review. Clin J Pain 2002; 18 (Suppl 6): S169-76.
-
(2002)
Clin J Pain
, vol.18
, Issue.SUPPL. 6
-
-
Loder, E.1
Biondi, D.2
-
32
-
-
4744344348
-
Botulinum toxin type A in the preventive treatment of refractory headaches-comparison between medication overuse and nonmedication overusers groups
-
Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM. Botulinum toxin type A in the preventive treatment of refractory headaches-comparison between medication overuse and nonmedication overusers groups [poster]. Cephalalgia 2003; 23: 715.
-
(2003)
Cephalalgia
, vol.23
, pp. 715
-
-
Tepper, S.J.1
Bigal, M.E.2
Sheftell, F.D.3
Rapoport, A.M.4
-
33
-
-
0036692121
-
The use of botulinum toxin in the treatment of headaches
-
Mauskop A. The use of botulinum toxin in the treatment of headaches. Curr Pain Headache Rep 2002; 6: 320-3.
-
(2002)
Curr Pain Headache Rep
, vol.6
, pp. 320-323
-
-
Mauskop, A.1
-
34
-
-
38849161313
-
Toxina botulínica: Origen, estructura, actividad, farmacología y cinética
-
López del Val LJ, Castro A, eds. Barcelona: Masson
-
Bartolomé MR, Lazuna FJ. Toxina botulínica: origen, estructura, actividad, farmacología y cinética. In López del Val LJ, Castro A, eds. Toxina botulínica: aplicaciones terapéuticas. Barcelona: Masson; 2002. p. 3-22.
-
(2002)
Toxina Botulínica: Aplicaciones Terapéuticas
, pp. 3-22
-
-
Bartolomé, M.R.1
Lazuna, F.J.2
-
35
-
-
0042710491
-
Immunologic and other properties of therapeutic botulinum toxin serotypes
-
Brin MF, Hallet M, Jankovic J, eds. Philadelphia: Lippincott Williams and Wilkins
-
Aoki KR. Immunologic and other properties of therapeutic botulinum. toxin serotypes. In Brin MF, Hallet M, Jankovic J, eds. Scientific therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams and Wilkins; 2002. p. 103-14.
-
(2002)
Scientific Therapeutic Aspects of Botulinum Toxin
, pp. 103-114
-
-
Aoki, K.R.1
-
36
-
-
0037396608
-
Dynamics of motor nerve terminal remodelling unveiled using SNARE-cleaving toxins: The extent and duration are dictated by the sites of SNAP-25 truncation
-
Meunier FA, Lisk G, Sesardie D, Dolly JO. Dynamics of motor nerve terminal remodelling unveiled using SNARE-cleaving toxins: the extent and duration are dictated by the sites of SNAP-25 truncation. Mol Cell Neurobiol 2003; 22: 454-66.
-
(2003)
Mol Cell Neurobiol
, vol.22
, pp. 454-466
-
-
Meunier, F.A.1
Lisk, G.2
Sesardie, D.3
Dolly, J.O.4
-
37
-
-
4644369057
-
Spread of paralysis to nearby and distant noninjected muscles in a monkey hand model: Comparison of BoNT-B and BoNT-A
-
Brin MF, Hallet M, Jankovic J, eds. Philadelphia: Lippincott Williams and Wilkins
-
Arezzo JC, Mona S, Litwak MS, Caputo FA, Meyer KE, Shopp GM. Spread of paralysis to nearby and distant noninjected muscles in a monkey hand model: comparison of BoNT-B and BoNT-A. In Brin MF, Hallet M, Jankovic J, eds. Scientific therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams and Wilkins; 2002. p. 123-34.
-
(2002)
Scientific Therapeutic Aspects of Botulinum Toxin
, pp. 123-134
-
-
Arezzo, J.C.1
Mona, S.2
Litwak, M.S.3
Caputo, F.A.4
Meyer, K.E.5
Shopp, G.M.6
-
38
-
-
0033917504
-
Botulinum toxin type A as a migraine preventive treatment
-
Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. Headache 2000; 40: 445-50.
-
(2000)
Headache
, vol.40
, pp. 445-450
-
-
Silberstein, S.1
Mathew, N.2
Saper, J.3
Jenkins, S.4
-
39
-
-
0033668492
-
Botulinum toxin type A (Botox) for the treatment of migraine headaches: An open label study
-
Binder WJ. Botulinum toxin type A (Botox) for the treatment of migraine headaches: an open label study. Otolaryngol Head Neck Surg 2000; 123: 669-76.
-
(2000)
Otolaryngol Head Neck Surg
, vol.123
, pp. 669-676
-
-
Binder, W.J.1
-
40
-
-
4744374371
-
Efficacy and safety of botulinum toxin type A (Botox) in the prophylactic treatment of migraine
-
Seattle
-
Barrientos N, Chana P. Efficacy and safety of botulinum toxin type A (Botox) in the prophylactic treatment of migraine. 44th Annual Scientific American Headache Society Meeting. Seattle; 2002. p. S106.
-
(2002)
44th Annual Scientific American Headache Society Meeting
-
-
Barrientos, N.1
Chana, P.2
-
41
-
-
0043234545
-
Botulinum neurotoxin for the treatment of migraine and other primar headache disorders: From bench to bedside
-
Dodick D. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside. Headache 2003; 43 (Suppl 1): S25-33.
-
(2003)
Headache
, vol.43
, Issue.SUPPL. 1
-
-
Dodick, D.1
-
42
-
-
0042369054
-
The use of botulinum toxin type A in headache treatment
-
Mathew NT, Kaup AO. The use of botulinum toxin type A in headache treatment. Curr Treat Opin Neurol 2002; 4: 365-73.
-
(2002)
Curr Treat Opin Neurol
, vol.4
, pp. 365-373
-
-
Mathew, N.T.1
Kaup, A.O.2
-
43
-
-
0034758711
-
Review of botulinum toxin type A and its clinical applications in migraine headache
-
Silberstein SD. Review of botulinum toxin type A and its clinical applications in migraine headache. Expert Opin Pharmacother 2001; 2: 1649-54.
-
(2001)
Expert Opin Pharmacother
, vol.2
, pp. 1649-1654
-
-
Silberstein, S.D.1
-
44
-
-
0002661469
-
Botox for migraine: Double-blind, placebo-controlled, region-specific evaluation
-
Brin MF, Swope DM, O'Brian C, Abbasi S, Pogoda JM. Botox for migraine: double-blind, placebo-controlled, region-specific evaluation. Cephalalgia 2000; 20: 421-2.
-
(2000)
Cephalalgia
, vol.20
, pp. 421-422
-
-
Brin, M.F.1
Swope, D.M.2
O'Brian, C.3
Abbasi, S.4
Pogoda, J.M.5
-
45
-
-
4744345565
-
Survey expenditure for analgesics in chronic tension headache and its changes following botulinum toxin type A preventive treatment
-
Olensen J, Silberstein SD, Tfelt-Hansen P, eds. New York: Oxford University Press
-
Coloprisco G, De Filippis S, Santi PG, Fiore G, Rodio A, Martelleti P. Survey expenditure for analgesics in chronic tension headache and its changes following botulinum toxin type A preventive treatment. In Olensen J, Silberstein SD, Tfelt-Hansen P, eds. Preventive pharmacotherapy of headaches disorders. Frontiers in headache research. New York: Oxford University Press; 2004. p. 163-7.
-
(2004)
Preventive Pharmacotherapy of Headaches Disorders. Frontiers in Headache Research
, pp. 163-167
-
-
Coloprisco, G.1
De Filippis, S.2
Santi, P.G.3
Fiore, G.4
Rodio, A.5
Martelleti, P.6
-
46
-
-
0346094042
-
Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patients
-
Schim J. Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patients. Curr Med Res Opin 2004; 20: 49-53.
-
(2004)
Curr Med Res Opin
, vol.20
, pp. 49-53
-
-
Schim, J.1
-
47
-
-
4744345564
-
Botulinum toxin A in the prophylaxis of migraine: A double-blind, placebo-controlled, randomized study comparing frontal and cervical injection
-
Olensen J, Silberstein SD, Tfelt-Hansen P, eds. New York: Oxford University Press
-
Schwaag S, Rahmann A, Frese A, Husstedt I-W, Vollmer-Haase J, Evers S. Botulinum toxin A in the prophylaxis of migraine: a double-blind, placebo-controlled, randomized study comparing frontal and cervical injection. In Olensen J, Silberstein SD, Tfelt-Hansen P, eds. Preventive pharmacotherapy of headaches disorders. Frontiers in headache research. New York: Oxford University Press; 2004. p. 142-8.
-
(2004)
Preventive Pharmacotherapy of Headaches Disorders. Frontiers in Headache Research
, pp. 142-148
-
-
Schwaag, S.1
Rahmann, A.2
Frese, A.3
Husstedt, I.-W.4
Vollmer-Haase, J.5
Evers, S.6
-
48
-
-
0347123546
-
Botulinum toxin type A (Botox) in the treatment of migraine and other headaches
-
Troost BT. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches. Expert Revisions Neurotherapeutics 2004; 4: 27-31.
-
(2004)
Expert Revisions Neurotherapeutics
, vol.4
, pp. 27-31
-
-
Troost, B.T.1
-
49
-
-
0038211994
-
'Disease modification' in chronic migraine with botulinum toxin type A: Long-term experience
-
Mathew N, Kallasam J, Kaupp A, Meadors L. 'Disease modification' in chronic migraine with botulinum toxin type A: long-term experience. Headache 2002; 42: 454.
-
(2002)
Headache
, vol.42
, pp. 454
-
-
Mathew, N.1
Kallasam, J.2
Kaupp, A.3
Meadors, L.4
-
50
-
-
0036834143
-
Treatment of headache with botulinum toxin A: A review according to evidence-based medicine criteria
-
Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Treatment of headache with botulinum toxin A: a review according to evidence-based medicine criteria. Cephalalgia 2002; 22: 699-710.
-
(2002)
Cephalalgia
, vol.22
, pp. 699-710
-
-
Evers, S.1
Rahmann, A.2
Vollmer-Haase, J.3
Husstedt, I.W.4
-
51
-
-
0038167467
-
Is there a role for botulinum toxin in the treatment of migraine?
-
Evers S. Is there a role for botulinum toxin in the treatment of migraine? Curr Pain Headache Rep 2003; 7: 229-34.
-
(2003)
Curr Pain Headache Rep
, vol.7
, pp. 229-234
-
-
Evers, S.1
-
52
-
-
0042232391
-
Synaptic transmission: Inhibition of neurotransmitter release by botulinum toxins
-
Dolly O. Synaptic transmission: Inhibition of neurotransmitter release by botulinum toxins. Headache 2003; 43 (Suppl 1): S16-24.
-
(2003)
Headache
, vol.43
, Issue.SUPPL. 1
-
-
Dolly, O.1
-
53
-
-
0042232400
-
Evidence for antinociceptive activity of botulinum toxin type A in pain management
-
Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003; 43 (Suppl 1): S9-15.
-
(2003)
Headache
, vol.43
, Issue.SUPPL. 1
-
-
Aoki, K.R.1
-
54
-
-
1642568305
-
Regulation of calcitonin-gene related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy
-
Durham PL, Cady R, Cady R. Regulation of calcitonin-gene related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 2004; 44: 35-43.
-
(2004)
Headache
, vol.44
, pp. 35-43
-
-
Durham, P.L.1
Cady, R.2
Cady, R.3
-
55
-
-
0035656457
-
Botulinum toxin type A and EMG: A key to the understanding of chronic tension-type headaches?
-
Rollnik JD, Karst M, Fink M, Dengler R. Botulinum toxin type A and EMG: a key to the understanding of chronic tension-type headaches? Headache 2001; 41: 985-9.
-
(2001)
Headache
, vol.41
, pp. 985-989
-
-
Rollnik, J.D.1
Karst, M.2
Fink, M.3
Dengler, R.4
-
56
-
-
0037322405
-
Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin
-
Kramer HH, Angerer C, Erbguth F, Schmelz M, Birklein H. Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. J Neurol 2003; 250: 188-93.
-
(2003)
J Neurol
, vol.250
, pp. 188-193
-
-
Kramer, H.H.1
Angerer, C.2
Erbguth, F.3
Schmelz, M.4
Birklein, H.5
-
57
-
-
4744343159
-
The trigeminal complex and migraine: Current concepts and synthesis
-
Bartsch T, Goadsby PJ. The trigeminal complex and migraine: current concepts and synthesis. Curr Pain Headache Rep 2003; 2: 149-54.
-
(2003)
Curr Pain Headache Rep
, vol.2
, pp. 149-154
-
-
Bartsch, T.1
Goadsby, P.J.2
-
59
-
-
0025908846
-
Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofacial inputs
-
Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofacial inputs. Pain 1991; 46: 125-32.
-
(1991)
Pain
, vol.46
, pp. 125-132
-
-
Olesen, J.1
-
60
-
-
0036782213
-
Botulinum toxin therapy for myofascial pain disorders
-
Lang AM. Botulinum toxin therapy for myofascial pain disorders. Curr Pain Headache Rep 2002; 6: 355-60.
-
(2002)
Curr Pain Headache Rep
, vol.6
, pp. 355-360
-
-
Lang, A.M.1
-
61
-
-
0035076007
-
Pharmacology and immunology of botolinum toxin serotypes
-
Aoki KR. Pharmacology and immunology of botolinum toxin serotypes. J Neurol 2001; 248 (Suppl 1): 13-10.
-
(2001)
J Neurol
, vol.248
, Issue.SUPPL. 1
, pp. 13-10
-
-
Aoki, K.R.1
-
62
-
-
4744347289
-
Aspectos generales de la aplicación de la toxina botulínica
-
López del Val LJ, Castro A, eds. Barcelona: Masson
-
López del Val LJ, Castro A, Vinagre I, López EL. Aspectos generales de la aplicación de la toxina botulínica. In López del Val LJ, Castro A, eds. Toxina botulínica: aplicaciones terapéuticas. Barcelona: Masson; 2002. p. 23-48.
-
(2002)
Toxina Botulínica: Aplicaciones Terapéuticas
, pp. 23-48
-
-
López Del Val, L.J.1
Castro, A.2
Vinagre, I.3
López, E.L.4
-
63
-
-
4744346674
-
Managing patients with botulinum toxin antibodies
-
Brin MF, Hallet M, Jankovic J, eds. Philadelphia: Lippincott Williams & Wilkins
-
Dressler D. Managing patients with botulinum toxin antibodies. In Brin MF, Hallet M, Jankovic J, eds. Scientific therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 417-26.
-
(2002)
Scientific Therapeutic Aspects of Botulinum Toxin
, pp. 417-426
-
-
Dressler, D.1
-
64
-
-
0023227635
-
Amynoglycosides and 3,4 diaminopyridine on neuromuscular block caused by botulinum type A toxin
-
Molgio J, Lemeignan M, Thesleff S. Amynoglycosides and 3,4 diaminopyridine on neuromuscular block caused by botulinum type A toxin. Muscle Nerve 1987; 10: 464-70.
-
(1987)
Muscle Nerve
, vol.10
, pp. 464-470
-
-
Molgio, J.1
Lemeignan, M.2
Thesleff, S.3
-
65
-
-
0011111710
-
Botulinum toxin type A Botox for pain and headache
-
Brin MF, Hallet M, Jankovic J, eds. Philadelphia: Lippincott Williams and Wilkins
-
Brin MF, Binder W, Blitzer A, Schenrock L, Pogoda JM. Botulinum toxin type A Botox for pain and headache. In Brin MF, Hallet M, Jankovic J, eds. Scientific therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams and Wilkins; 2002. p. 233-50.
-
(2002)
Scientific Therapeutic Aspects of Botulinum Toxin
, pp. 233-250
-
-
Brin, M.F.1
Binder, W.2
Blitzer, A.3
Schenrock, L.4
Pogoda, J.M.5
|